The developed ASOs efficiently induced exon skipping with an IC50 of 3.5–7 nM, disrupting the GLDC open reading frame and resulting in the inhibition of cell proliferation and colony formation in A549 cells and NSCLC tumor spheres (TS32). This evidence concerns the gene GLDC and non-small cell lung carcinoma.